Icon

DAURISMO (nda210656)- (EQ 25MG BASE,EQ 100MG BASE)

GLASDEGIB MALEATE PFIZER
EQ 25MG BASE,EQ 100MG BASE
No No
2036-Apr-13 2023-Nov-21
None None
None No
DAURISMO is a hedgehog pathway inhibitor indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 25MG BASE ** ** - - -
EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.